Screening Potential Drugs for the Development of NAFLD Based on Drug Perturbation Gene Set

Nonalcoholic fatty liver disease (NAFLD) has become one of the problems affecting the health of the population worldwide. The progressive disease includes nonalcoholic steatohepatitis (NASH) and fibrosis, which with no approved therapy, system identification of effective drugs remains challenging. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Zhengzheng, Dai, Lina, Zhang, Haifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034918/
https://www.ncbi.nlm.nih.gov/pubmed/35469222
http://dx.doi.org/10.1155/2022/7606716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034918/
https://www.ncbi.nlm.nih.gov/pubmed/35469222
http://dx.doi.org/10.1155/2022/7606716

Ejemplares similares